Subsequent studies have identified different strategies with benefit in progeria mice, including sodium salicylate (Osorio et al., 2012), splicing therapies (Osorio et al., 2011), reprogramming (Ocampo et al., 2016), and reduced NF‐κB signaling (Osorio et al., 2012). Here, NFKB1 is linked to progeroid syndrome.